Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study

Alyn Morice, Jaclyn A Smith, Lorcan McGarvey, Surinder S Birring, Sean M Parker, Alice Turner, Thomas Hummel, Isabella Gashaw, Lueder Fels, Stefan Klein, Klaus Francke, Christian Friedrich

Research output: Contribution to journal › Article › peer-review

66 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study'. Together they form a unique fingerprint.

Medicine & Life Sciences